InvestorsHub Logo
Followers 59
Posts 7642
Boards Moderated 0
Alias Born 07/27/2012

Re: None

Friday, 09/21/2018 3:19:39 PM

Friday, September 21, 2018 3:19:39 PM

Post# of 55249
"...The company’s new approach to cell growth has already been applied to the repair of tendons and joints. The technology has also been applied to the re-growth of pancreas and heart tissue. Rejection does not occur as the new cells are from that individual and are recognised by the body as non foreign. It is our belief that this new method of cell growth will be successfully used for cell and organ repair in many parts of the human body..."

new: "...Therapy Cells announces a new license granted to Contravaccine Ltd. This license enables Contravaccine to grow a line of granulosa cells for use in NON-Surgical sterilisation of Cats and Dogs! This joint venture is in final clinical testing with access to the existing $650 Million/Annum North American spey market..."

GL